Brief: Arctic Bioscience Q4 Adjusted EBITDA NOK -9.9 Million
01/03/2024 07:00
Mar 01 (Reuters) - Arctic Bioscience Q4 gross margin 17.1%. * Q4 gross profit NOK 1.7 million * Q4 revenue NOK 9.9 million
Recent news on Arctic Bioscience AS
See all newsNorway's Arctic Bioscience Q1 sales rise 78% to record on America boost
Brief: Arctic Bioscience Q1 Adjusted EBITDA NOK -6.5 Million
Norway's Arctic Bioscience 2025 revenue falls due to product recall impact
Brief: Arctic Bioscience Q3 Adjusted EBITDA NOK -7.8 Million
Brief: Arctic Bioscience H1 Adjusted EBITDA NOK -13.6 Million